Lazard Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $45K | Sell |
|
|||||
|
2024
Q4 | $70K | Sell |
|
|||||
|
2024
Q3 | $216K | Hold |
|
|||||
|
2024
Q2 | $181K | Buy |
|
|||||
|
2024
Q1 | $86K | Hold |
|
|||||
|
2023
Q4 | $84K | Hold |
|
|||||
|
2023
Q3 | $71K | Buy |
|
|||||
|
2023
Q2 | $39K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $485K | Sell |
|
|||||
|
2022
Q3 | $625K | Buy |
|
|||||
|
2022
Q2 | $79K | Hold |
|
|||||
|
2022
Q1 | $99K | Buy |
|
|||||
|
2021
Q4 | $133K | Buy |
|
|||||
|
2021
Q3 | $111K | Sell |
|
|||||
|
2021
Q2 | $114K | Buy |
|
|||||
|
2021
Q1 | $131K | Hold |
|
|||||
|
2020
Q4 | $85K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $542K | Buy |
|
|||||
|
2019
Q2 | $258K | Sell |
|
|||||
|
2019
Q1 | $449K | Buy |
|
|||||
|
2018
Q4 | $141K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $867K | Buy |
|